37.10

0.24% 0.09

After Hours: 37.36 0.26 +0.70%

Kiniksa Pharmaceuticals International Plc (KNSA)

Overview News Price History Option Chain Financials Discussions Forecast

Kiniksa Pharmaceuticals International Plc stock is traded at $37.10, with a volume of 395.97K. It is up +0.24% in the last 24 hours and up +13.18% over the past month. Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

Previous Close:

$37.01

Open:

$37.02

24h Volume:

395.97K

Relative Volume:

0.55

Market Cap:

$1.61B

Revenue:

$384.10M

Net Income/Loss:

$-9.07M

P/E Ratio:

-265.00

EPS:

-0.14

Net Cash Flow:

$11.10M

1W Performance:

+3.89%

1M Performance:

+13.18%

6M Performance:

+64.89%

1Y Performance:

+51.49%

1-Day Range:

$36.40

$37.34

1-Week Range:

$35.45

$37.34

52-Week Range:

$17.82

$37.34

Kiniksa Pharmaceuticals International Plc Stock (KNSA) Company Profile

Name

Kiniksa Pharmaceuticals International Plc

Sector

Healthcare (1152)

Industry

Drug Manufacturers - Specialty & Generic (84)

Phone

(781) 431-9100

Address

23 OLD BOND STREET, FLOOR 3, LONDON

Employee

315

Twitter

@kiniksa

Next Earnings Date

2024-10-29

Latest SEC Filings

KNSA's Discussions on Twitter

Compare KNSA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
KNSA Kiniksa Pharmaceuticals International Plc	37.10	2.68B	384.10M	-9.07M	11.10M	-0.14
ZTS Zoetis Inc	148.20	66.22B	9.39B	2.62B	2.22B	5.81
TAK Takeda Pharmaceutical Co Adr	15.10	48.29B	29.96B	957.25M	4.77B	0.304
HLN Haleon Plc Adr	9.81	43.99B	14.26B	1.98B	2.47B	0.4347
TEVA Teva Pharmaceutical Industries Ltd Adr	19.93	22.45B	16.70B	-157.13M	1.19B	-0.155
UTHR United Therapeutics Corp	405.02	17.93B	2.99B	1.21B	1.13B	25.06

Kiniksa Pharmaceuticals International Plc Stock (KNSA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-13-25	Initiated	Citigroup	Buy
Sep-13-24	Initiated	Jefferies	Buy
May-03-24	Initiated	Wells Fargo	Overweight
Jun-29-20	Reiterated	BofA Securities	Buy
Apr-01-20	Initiated	BofA/Merrill	Buy
Mar-11-19	Initiated	Barclays	Overweight
Dec-12-18	Reiterated	Wedbush	Outperform
Jun-19-18	Initiated	JMP Securities	Mkt Outperform

View All

Kiniksa Pharmaceuticals International Plc Stock (KNSA) Latest News

Sep 12, 2025

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) COO Sells $477,451.74 in Stock - MarketBeat

Sep 12, 2025

Eben Tessari Sells 85,271 Shares of Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock - MarketBeat

Sep 12, 2025

Sep 11, 2025

American Century Companies Inc. Trims Stake in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Sep 11, 2025

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Reaches New 12-Month HighWhat's Next? - MarketBeat

Sep 11, 2025

Sep 10, 2025

Cubist Systematic Strategies LLC Takes $4.66 Million Position in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Sep 10, 2025

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Insider Ross Moat Sells 3,523 Shares - MarketBeat

Sep 10, 2025

Granahan Investment Management LLC Has $8.04 Million Stock Holdings in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Sep 10, 2025

Sep 09, 2025

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) CAO Michael R. Megna Sells 11,000 Shares - MarketBeat

Sep 09, 2025

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Hits New 12-Month HighWhat's Next? - MarketBeat

Sep 09, 2025

PDT Partners LLC Cuts Stock Position in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Sep 09, 2025

Insider Selling: Kiniksa Pharmaceuticals International (NASDAQ:KNSA) COO Sells 15,091 Shares of Stock - MarketBeat

Sep 09, 2025

Sep 08, 2025

Kiniksa Pharma: Chief corp officer Moat Ross sells $124k in shares - Investing.com Canada

Sep 08, 2025

Kiniksa Pharma COO Tessari sells shares worth $3.5m - Investing.com

Sep 08, 2025

Ieq Capital LLC Purchases New Stake in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Sep 08, 2025

169,864 Shares in Kiniksa Pharmaceuticals International, plc $KNSA Purchased by Vestal Point Capital LP - MarketBeat

Sep 08, 2025

Corebridge Financial Inc. Buys 549 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - Defense World

Sep 08, 2025

Invesco Ltd. Raises Stock Holdings in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Sep 08, 2025

Sep 07, 2025

Birchview Capital LP Makes New Investment in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Sep 07, 2025